Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up Registry
Dirk Sandig, Julia M. Grimsmann, Christina Reinauer, et al.
Diabetes Technology & Therapeutics (2020) Vol. 22, Iss. 8, pp. 602-612
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

7. Diabetes Technology: Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S111-S127
Open Access | Times Cited: 236
7. Diabetes Technology: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S126-S144
Open Access | Times Cited: 143
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial
Margaretha M. Visser, Sara Charleer, Steffen Fieuws, et al.
The Lancet (2021) Vol. 397, Iss. 10291, pp. 2275-2283
Open Access | Times Cited: 140
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022

Diabetes Care (2021) Vol. 45, Iss. Supplement_1, pp. S97-S112
Open Access | Times Cited: 104
7. Diabetes Technology: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S146-S166
Open Access | Times Cited: 24
Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial
Margaretha M. Visser, Sara Charleer, Steffen Fieuws, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 2, pp. 96-108
Closed Access | Times Cited: 39
Impact of the initiation of isCGM soon after type 1 diabetes mellitus diagnosis in adults on glycemic indices and fear of hypoglycemia: a randomized controlled trial
Jerzy Hohendorff, Agata Grzelka-Wozniak, Marta Wróbel, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Evaluation of glycemia risk index and continuous glucose monitoring-derived metrics in type 1 diabetes: a real-world observational study
Ayman Al Hayek, Malak Al Mashali, Mohamed Abdulaziz Al Dawish
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access
Glucometrics and Patient-Reported Outcomes in Individuals With Type 1 Diabetes Mellitus: Insights From the Correlation of Time in Range (CorrelaTIR) Study in Real-World Settings
Esther Artime, Natalia Hillman, Francisco J. Tinahones, et al.
Cureus (2025)
Open Access
Ultrarapid Lispro Demonstrates Similar Time in Target Range to Lispro with a Hybrid Closed-Loop System
Bruce W. Bode, Anders L. Carlson, Rong Liu, et al.
Diabetes Technology & Therapeutics (2021) Vol. 23, Iss. 12, pp. 828-836
Open Access | Times Cited: 29
To evaluate the use and clinical effect of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: Results of a multicentre study
Jesús Moreno-Fernández, Julia Sastre, Pedro Pinés, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2023) Vol. 70, Iss. 4, pp. 270-276
Closed Access | Times Cited: 9
Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI
Marcus Lind, Arndís F. Ólafsdóttir, Irl B. Hirsch, et al.
Diabetes Care (2020) Vol. 44, Iss. 1, pp. 141-149
Open Access | Times Cited: 27
Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations – a registry-based analysis
Peter Bramlage, Stefanie Lanzinger, Sascha R. Tittel, et al.
BMC Nephrology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Cost–utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium
Margaretha M. Visser, Astrid Van Muylder, Sara Charleer, et al.
Diabetologia (2024) Vol. 67, Iss. 4, pp. 650-662
Closed Access | Times Cited: 2
Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry
Zdenĕk Šumnı́k, Markéta Pavlı́ková, Renata Pomahačová, et al.
Pediatric Diabetes (2021) Vol. 22, Iss. 3, pp. 439-447
Open Access | Times Cited: 17
Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme
M. Gaudillère, C. Pollin-Javon, S. Brunot, et al.
Diabetes & Metabolism (2021) Vol. 47, Iss. 6, pp. 101251-101251
Open Access | Times Cited: 17
Personal Glycation Factors and Calculated Hemoglobin A1c for Diabetes Management: Real-World Data from the Diabetes Prospective Follow-up (DPV) Registry
Yongjin Xu, Julia M. Grimsmann, Beate Karges, et al.
Diabetes Technology & Therapeutics (2021) Vol. 23, Iss. 6, pp. 452-459
Open Access | Times Cited: 16
Real-World Studies Support Use of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes Independently of Treatment Regimen
James R. Gavin, Clifford J. Bailey
Diabetes Technology & Therapeutics (2021) Vol. 23, Iss. S3, pp. S-27
Open Access | Times Cited: 16
The Role of Retrospective Data Review in the Personal Use of Real-Time Continuous Glucose Monitoring: Perceived Impact on Quality of Life and Health Outcomes
William H. Polonsky, Emily C. Soriano, Addie L. Fortmann
Diabetes Technology & Therapeutics (2022) Vol. 24, Iss. 7, pp. 492-501
Closed Access | Times Cited: 11
Posttraumatic stress disorder and diabetes-related outcomes in patients with type 1 diabetes
Frederike Lunkenheimer, Alexander J. Eckert, Dörte Hilgard, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Continuous glucose monitoring in older adults with diabetes: Data from the diabetes prospective follow‐up (DPV) registry
Jennifer Grammes, Stefanie Schmid, Latife Bozkurt, et al.
Diabetic Medicine (2023) Vol. 41, Iss. 3
Open Access | Times Cited: 6
The Ambulatory Glucose Profile: Opportunities for Enhancement
David Rodbard
Diabetes Technology & Therapeutics (2020) Vol. 23, Iss. 5, pp. 332-341
Closed Access | Times Cited: 16
Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria
Rodolfo J. Galindo, Grazia Aleppo, Christopher G. Parkin, et al.
Journal of Diabetes Science and Technology (2022) Vol. 18, Iss. 4, pp. 974-987
Open Access | Times Cited: 10
Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring
Stefanie Lanzinger, F. Best, Tanja Bergmann, et al.
Diabetes Technology & Therapeutics (2022) Vol. 24, Iss. 10, pp. 763-769
Open Access | Times Cited: 8
Real‐world glycaemic outcomes in adult persons with type 1 diabetes using a real‐time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL‐CGM‐T1D)
Ruth E. Brown, Lisa Chu, Gregory J. Norman, et al.
Diabetic Medicine (2022) Vol. 39, Iss. 11
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top